ABArjen J. Boender

Arjen J. Boender

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arjen J. Boender has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Oxytocin facilitates social behavior of female rats via selective modulation of interneurons in the medial prefrontal cortex

    by Stephanie Schimmer, Alan Kania, Arthur Lefevre, Konstantinos Afordakos, Kai-Yi Wang, Julia Lebedeva, Andrei Rozov, Androniki Raftogianni, Rishika Tiwari, Shai Netser, et al.

    The hypothalamic neuropeptide oxytocin is best known for its prosocial behavioral effects. However, the precise anatomical and cellular targets for oxytocin in the cortex during social behavior remain elusive. Here we show that oxytocin neurons project directly to the medial prefrontal cortex where evoked axonal oxytocin release facilitates social behaviors in adult female rats. In conjunction, we report that local oxytocin receptor-expressing (OTR + ) cells are predominantly interneurons, whose activation promotes social interaction. Notably, this prosocial effect persists even under physiological challenge (hunger), pointing to a dedicated prosocial circuit capable of overriding primary survival drives. We further demonstrate that activation of these OTR + interneurons inhibits principal cells specifically projecting to the basolateral amygdala, thus providing a putative mechanism of selective oxytocin action in this sociability-promoting cortical network.


  • Open Access

    Comparative gene editing reduces dopamine receptor levels across rodent species

    by Sonia C. Karkare, Dario Aspesi, Keith M. Garner, Evelien H.S. Schut, H. Elliott Albers, Frank J. Meye, Malavika Murugan, Arjen J. Boender

    Translational challenges in neuroscience originate from species-specific differences that limit the generalizability of experimental findings. Comparative approaches can help distinguish conserved from species-specific mechanisms, but their application has been limited by the lack of molecular tools beyond traditional model organisms, complicating direct comparisons of conserved and divergent mechanisms of neural function. This gap is particularly evident for the dopaminergic system, a key regulator of motivated behaviors across species and the principal pharmacological target for current psychotherapies. Building on our recent development of comparative gene editing, we here present an adeno-associated virus-mediated CRISPR/Cas9 strategy to reduce in vivo dopamine receptors D1 and D2 levels across the rodent phylogeny. Using this approach, we achieved specific reduction of receptor levels in three rodent species (house mouse, prairie vole, and Syrian hamster), which we demonstrate with radioactive ligand binding assays. This toolkit expands the reach of comparative gene editing approaches, enabling functional investigation of the dopaminergic system across rodent species. Thereby, it supports comparative neuroscience by facilitating the identification of conserved versus species-specific neural mechanisms with enhanced translational potential.

  • Open Access

    Natural variation in oxytocin receptor signaling causes widespread changes in brain transcription: a link to the natural killer gene complex

    by Arjen J. Boender, Zachary V. Johnson, Kayla K. Green, George W. Gruenhagen, Brianna E. Hegarty, Kengo Horie, Kiyoshi Inoue, Ewoud R.E. Schmidt, Jeffrey T. Streelman, Hasse Walum, et al.

    Oxytocin (OXT) is a highly conserved neuropeptide that modulates social cognition, and genetic variation in its receptor gene ( Oxtr ) is linked to divergent social phenotypes. However, the molecular mechanisms connecting Oxtr genotype to behavioral outcomes remain obscure. Here, we leverage naturally occurring Oxtr polymorphisms in the prairie vole that associate with striatal-specific OXTR density to investigate how OXTR signaling influences brain function. Specifically, we identify OXTR-dependent transcriptomic changes in the natural killer gene complex (NKC) - a genomic region classically associated with peripheral immune function. Centrally, OXTR-regulated NKC genes are positioned to influence microglia-neuron interactions. Consistent with a role for these genes in shaping neuronal connectivity, we show that genetic reduction of OXTR levels leads to increased dendritic spine density on striatal Oxtr -expressing neurons. In addition, we provide support for a similar relation between variation in OXTR mRNA levels and NKC transcription in humans. Together, our findings suggest a role for OXTR signaling in the shaping of neural circuits through transcriptional control of the NKC, outlining a mechanism via which variation in OXTR signaling may influence circuit connectivity to generate diversity in social behaviors.


  • Open Access

    An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept

    by Arjen J. Boender, Marina Boon, H. Elliott Albers, Samantha R. Eck, Brandon A. Fricker, Aubrey M. Kelly, Joseph E. LeDoux, Simone C. Motta, Prerana Shrestha, Jack H. Taylor, et al.

    A major issue in neuroscience is the poor translatability of research results from preclinical studies in animals to clinical outcomes. Comparative neuroscience can overcome this barrier by studying multiple species to differentiate between species-specific and general mechanisms of neural circuit functioning. Targeted manipulation of neural circuits often depends on genetic dissection, and use of this technique has been restricted to only a few model species, limiting its application in comparative research. However, ongoing advances in genomics make genetic dissection attainable in a growing number of species. To demonstrate the potential of comparative gene editing approaches, we developed a viral-mediated CRISPR/Cas9 strategy that is predicted to target the oxytocin receptor ( Oxtr ) gene in >80 rodent species. This strategy specifically reduced OXTR levels in all evaluated species ( n = 6) without causing gross neuronal toxicity. Thus, we show that CRISPR/Cas9-based tools can function in multiple species simultaneously. Thereby, we hope to encourage comparative gene editing and improve the translatability of neuroscientific research.


  • Striatal Astrocytes Shape Behavioral Flexibility via Regulation of the Glutamate Transporter EAAT2

    by Arjen J. Boender, Leonardo Bontempi, Luca Nava, Yann Pelloux, Raffaella Tonini


  • Open Access

    Plasticity of the glutamate transporter EAAT2 on striatal astrocytes regulates flexibility in behavior

    by Arjen J. Boender, Raffaella Tonini

    Modulation of striatal circuits is necessary for behavioral flexibility and confers the ability to adapt to environmental changes. Striatal astrocytes contribute to circuit neuromodulation by controlling the activity of ambient neurotransmitters. In particular, extracellular glutamate levels are tightly controlled by the astrocytic glutamate transporter EAAT2, thereby influencing synaptic functioning and neural network activity. While disturbances in EAAT2 have been related to neurological dysfunctions, it remains unclear if environmental cues influence this protein’s function to specifically shape action control. In this study, we investigate the relationship between experience-dependent plasticity of EAAT2 expression and action inflexibility that follows overtraining for an instrumental task. We find that task overtraining is associated with the upregulation of EAAT2 in the lateral part of the dorsal striatum (DLS). Interfering with EAAT2 upregulation by chemogenetic activation of astrocytic Gq signaling or by transient in vivo knockdown of EAAT2 in the DLS restores behavioral flexibility. Astrocytes are emerging as critical regulators of striatal functions, and by demonstrating that plasticity of EAAT2 expression in the DLS shapes behavior, this work provides novel mechanistic insights into how flexibility in action control is regulated.

  • Open Access

    Deletion of astrocytic BMAL1 results in metabolic imbalance and shorter lifespan in mice

    by Olga Barca‐Mayo, Arjen J. Boender, Andrea Armirotti, Davide De Pietri Tonelli

    Disruption of the circadian cycle is strongly associated with metabolic imbalance and reduced longevity in humans. Also, rodent models of circadian arrhythmia, such as the constitutive knockout of the clock gene Bmal1, leads to metabolic disturbances and early death. Although astrocyte clock regulates molecular and behavioral circadian rhythms, its involvement in the regulation of energy balance and lifespan is unknown. Here, we show that astrocyte‐specific deletion of Bmal1 is sufficient to alter energy balance, glucose homeostasis, and reduce lifespan. Mutant animals displayed impaired hypothalamic molecular clock, age‐dependent astrogliosis, apoptosis of hypothalamic astrocytes, and increased glutamate and GABA levels. Importantly, modulation of GABAA‐receptor signaling completely restored glutamate levels, delayed the reactive gliosis as well as the metabolic phenotypes and expanded the lifespan of the mutants. Our results demonstrate that the astrocytic clock can influence many aspects of brain function and neurological disease and suggest astrocytes and GABAA receptor as pharmacological targets to prevent the metabolic dysfunctions and shortened lifespan associated with alterations of circadian rhythms.


  • A light-gated potassium channel for sustained neuronal inhibition

    by Laura Alberio, Andrea Locarno, Andrea Saponaro, Edoardo Romano, Valérie Bercier, Shahad Albadri, Federica Simeoni, Silvia Moleri, Silvia Pelucchi, Alessandro Porro, et al.

    Currently available inhibitory optogenetic tools provide short and transient silencing of neurons, but they cannot provide long-lasting inhibition because of the requirement for high light intensities. Here we present an optimized blue-light-sensitive synthetic potassium channel, BLINK2, which showed good expression in neurons in three species. The channel is activated by illumination with low doses of blue light, and in our experiments it remained active over (tens of) minutes in the dark after the illumination was stopped. This activation caused long periods of inhibition of neuronal firing in ex vivo recordings of mouse neurons and impaired motor neuron response in zebrafish in vivo. As a proof-of-concept application, we demonstrated that in a freely moving rat model of neuropathic pain, the activation of a small number of BLINK2 channels caused a long-lasting (>30 min) reduction in pain sensation.